11 research outputs found
Effect of barbiturates and benzodiazepines on local kainate toxicity in the Striatum and in the retina. In: Adv. Biochem. Psychopharmacol.,
Non disponibili
Involvment of D1 and D2 dopamine receptors in the control of horizontal cell electrical coupling in the turtle retina
We studied the actions of D1 and D2 dopamine agonists and antagonists on the coupling of horizontal cell axons in the turtle retina by a combination of pharmacological and electrophysiological methods. Both D1 and D2 receptors were identified in membrane fractions by radioligand binding using [3H]-SCH 23390 and [3H]-spiperone, respectively. The KD of both receptor classes were identical (0.21 nM) but D1 receptor density exceeded that of D2 receptors by more than four-fold. D1 agonists increased the activity of adenylate cyclase in a dose-dependent manner, whereas D2 agonists were without significant effect by themselves, nor did D2 antagonists block the D1-mediated increase in adenylate cyclase activity. Intracellular recordings and Lucifer Yellow dye injections were used to characterize the modifications of the receptive field profile of horizontal cell axons (H1AT) exposed to different pharmacological agents. Dopamine or D1 agonists (0.05 - 10 microM) induced a marked constriction of the H1AT receptive field, whereas D2 agonists elicited a small expansion of the receptive field. However, in the presence of a D1 antagonist, as well as IBMX to inhibit phosphodiesterase, D2 agonists (10 - 70 microM) induced a marked increase in the receptive field profile. These results indicate that both D1 and D2 dopamine receptors play a role in shaping the receptive field profile of the horizontal cell axon terminal in the turtle retina
Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone
Influence of domiciliary humidification on symptom burden and feeding tube use up to 2 years postradiation therapy for head and neck cancer: Trans-Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM randomized phase 2 trial secondary analysis
ePoster Abstract #1126A.M.J. Macann, T. Fua, C.G. Milross, S. Porceddu, M.G. Penniment, C. Wratten, H. Krawitz, M.G. Poulsen, C.I. Tang, R.P. Morton, V. Thomson, M.L. Bell, M.T. King, C.L. Fraser-Browne, and H.U.P. Hocke